Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's disease
- 1 January 1992
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 32 (S1) , S105-S110
- https://doi.org/10.1002/ana.410320718
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian BrainsJournal of Neurochemistry, 1991
- Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases.Proceedings of the National Academy of Sciences, 1990
- Deficiencies in Complex I subunits of the respiratory chain in Parkinson's diseaseBiochemical and Biophysical Research Communications, 1989
- Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's DiseaseJournal of Neurochemistry, 1989
- Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian BrainsJournal of Neurochemistry, 1989
- Oxygen toxicity protecting enzymes in Parkinson's diseaseJournal of the Neurological Sciences, 1988
- Oxygen toxicity, oxygen radicals, transition metals and diseaseBiochemical Journal, 1984
- Parkinson's disease: A disorder due to nigral glutathione deficiency?Neuroscience Letters, 1982
- The effect of age on the activity and molecular properties of human brain monoamine oxidaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980
- Brain Peroxidase and Catalase in Parkinson DiseaseArchives of Neurology, 1975